the normal-pressure hydrocephalus segment can exhibit the highest CAGR of 4.92 % during the assessment period to reach a size of USD 345.07 million by 2023 .
By diagnosis , MRI can display 4.93 % CAGR during the assessment period to reach a value of USD 659.86 million by 2023 . This can be attributed to the effectiveness of MRI technology to scan malformations in the brain . On the other hand , the CT scan-head segment can display 3.86 % CAGR to accrue USD 756.21 million by 2023 . The application of the technology to gain the presence of the condition at an early stage in adults and infants can drive its growth .
By treatment , surgery-shunt insertion accounted for 59 % market share in 2017 , followed by ventriculostomy ( 22 %), medication ( 12 %), and others ( 7 %). The surgery-shunt insertion segment can display 4.12 % CAGR over the forecast period to generate close to USD 1,008.67 million by 2023 . Factors driving segment growth include approval of shunts , efficacy of shunts in deterring the accumulation of CSF , and preference of the treatment by the elderly . On the other hand , ventriculostomy can exhibit 4.92 % CAGR during the assessment period to generate close to USD 400.92 million by 2023 .
By end-user , diagnostic centers can exhibit 4.92 % CAGR during the assessment period to touch a value of USD 397.28 million by 2023 . Hospitals & clinics can generate USD 951.56 million by 2023 at a CAGR of 4.12 % CAGR throughout the forecast period .
Hydrocephalus Market Regional Analysis :
Region-wise , the hydrocephalus market includes Americas , Europe , Asia Pacific ( APAC ), and the Middle East & Africa ( MEA ). Americas held close to 36 % market share in 2017 , followed by Europe ( 32 %), APAC ( 24 %), and MEA ( 8 %).
The Americas region had dominated the market in 2017 owing to high incidence of traumatic brain injuries ( TBI ) and prevalence of neurovascular diseases . It can accrue close to USD 615.79 million by 2023 , at a CAGR of 3.80 % over the forecast period . The growth is facilitated by development of imaging technologies and shunts which can improve the surgical outcomes .
The APAC region can exhibit the highest CAGR of 5 % during the assessment period owing to high cases of accidents which cause TBI . The latent potential of economies of China and India coupled with the large patient pool can create opportunities for equipment manufacturers to establish their units . The region can generate USD 439.36 million by 2023 .
The Europe region can generate USD 555.63 million by 2023 at a CAGR of 4.61 % during the forecast period . This can be attributed to improvement of hydrocephalus management , continuous development of shunts , and upskilling of neurosurgeons .
Brows More Healthcare Related Research Reports :